🔎 Trials Near Me

Akèy › Myelofibroz › Ohio › Cleveland

Etid klinik pou Myelofibroz nan Cleveland, OH

9 etid pou Myelofibroz ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Ap rekriteFaz 3
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07623161

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT05320198

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

Ap rekriteFaz 1/2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT06773195

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07441694

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

Ap rekriteFaz 2
  • The Cleveland Clinic Foundation, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT05835466

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Ap rekriteFaz 1
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT06034002

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

Ap rekriteFaz 2
  • Cleveland Clinic, Cleveland
Laj 18 ak plis · Tout sèks · Mizajou Feb 12, 2026 · NCT05980806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi lwen
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

Ap rekriteFaz 3
  • Cleveland Clinic Cancer Center at Fairview Hospital, Cleveland
  • Cleveland Clinic, Cleveland
  • Hillcrest Hospital - Cleveland Clinic, Mayfield Heights · 12 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2025 · NCT06479135

Etid Myelofibroz nan lòt vil

Lòt etid nan Cleveland

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.